首頁 > 市場調查報告書 > 材料

包裝/容器

市場調查報告書

商品編碼

1733213

全球空膠囊市場規模：依最終用戶產業、產品、治療應用、區域範圍和預測

Global Empty Capsules Market Size By End-User Industry, By Product, By Therapeutic Application, By Geographic Scope And Forecast

出版日期: 2025年04月30日 | 出版商:

Verified Market Research | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄

空膠囊的市場規模及預測

2024年空膠囊市場規模價值為 30.7億美元，預計到2032年將達到 50.2億美元，2026年至2032年的年複合成長率為 7.00%。

空膠囊是藥品、化學品和粉末物質的重要載體，廣泛應用於製藥、營養保健品、化妝品和實驗室等各行業。

這些膠囊為固態劑型，主要用於口服和容納活性藥物成分（API）、草藥粉和維生素補充劑。

由於感染疾病和病毒性疾病的盛行率不斷上升，以及空膠囊應用範圍的擴大，空膠囊的需求預計也會成長。

此外，目的是提高製藥能力和增加公共和政府對醫療保健的投資的研發力度不斷加大，可能在未來幾年進一步推動空膠囊市場的擴張。

全球空膠囊市場動態

影響全球空膠囊市場的關鍵市場動態是：

關鍵市場促進因素

轉向便捷的劑型：根據國際藥用輔料理事會2022年的一項調查，68%的消費者選擇膠囊而不是其他口服劑型，因為它們易於吞嚥和攜帶。

無明膠膠囊的需求不斷增加：美國FDA 報告指出，2020年至2022年間，使用素食膠囊的新藥核准將增加 25%。

製藥業成長：根據世界衛生組織的報告，2021年全球醫藥品研究開發費用將比2020年增加5.5%，這將進一步增加對用於包裝新藥物製劑的空膠囊的需求。

主要問題

原料供應挑戰：聯合國糧食及農業組織（FAO）報告指出，由於COVID-19疫情導致牲畜供應和肉類營運中斷，2019年至2021年全球明膠產量將下降7.5％。

監管複雜性：2021年，美國FDA 實施了新的指導方針，要求提高藥品中使用的明膠來源的可追溯性和檢驗，增加了膠囊製造商的合規成本。歐洲藥品管理局報告指出，2020年至2022年期間，有關空膠囊成分和安全性的監管問詢數量增加了12%，減緩了新藥申請的核准流程。

來自替代品的競爭：根據國際藥用輔料理事會2022年的一項消費者調查，28%的受訪者更喜歡口溶錠而不是膠囊，理由是其起效更快是主要因素。

主要趨勢

素食/素食膠囊需求增加：國際藥用輔料理事會2021年的一項調查發現，65%的全球消費者積極尋求素食和純素食補充劑和藥品膠囊。

特種膠囊的成長：隨著製藥公司不斷創新以提高生物有效性和患者體驗，美國FDA 預計，利用特種膠囊技術的新藥申請將在2020年至2022年間成長 19%。

對明膠替代品的需求不斷增加：越來越多的飲食、文化和宗教因素推動了人們對無明膠膠囊的偏好。這一趨勢反映了多樣化的消費者偏好和市場需求，推動了對替代膠囊材料（如 HPMC 和普魯蘭膠膠囊等素食選擇）的需求。

Regulatory Complexity: The U.S. FDA implemented new guidelines in 2021 requiring enhanced traceability and verification for gelatin sources used in pharmaceutical products, leading to increased compliance costs for capsule producers. The European Medicines Agency reported a 12% increase in the number of regulatory queries related to empty capsule composition and safety from 2020 to 2022, slowing the approval process for new drug applications.

Competition from Alternative Delivery Forms: A 2022 consumer survey by the International Pharmaceutical Excipients Council found that 28% of respondents preferred orally disintegrating tablets over capsules, citing faster onset of action as a key driver.

Key Trends:

Rising Demand for Vegetarian & Plant-Based Capsules: A 2021 survey by the International Pharmaceutical Excipients Council found that 65% of consumers globally actively seek out vegetarian or vegan-friendly capsule options for supplements and medications.

Growth of Specialty Capsule Formats: The U.S. FDA saw a 19% increase in new drug applications utilizing specialized capsule technologies from 2020 to 2022, as pharmaceutical companies innovate to improve bioavailability and patient experience.

Increasing Demand for Gelatin Alternatives: Growing dietary, cultural, and religious considerations are leading to a rising preference for gelatin-free capsules. This trend reflects diverse consumer preferences and market needs, boosting demand for alternative capsule materials like vegetarian options, including HPMC and pullulan capsules.

Global Empty Capsules Market Regional Analysis

Here is a more detailed regional analysis of the global empty capsules market:

North America

North America substantially dominates the global empty capsules market driven by the large pharmaceutical industry and R&D investments.

According to the IQVIA Institute, the North American pharmaceutical market was valued at USD 612 Billion in 2020, accounting for nearly half of the global market.

The U.S. National Institutes of Health reported a 7.5% year-over-year increase in pharmaceutical R&D spending in the North American region from 2020 to 2021, reaching over USD 300 Billion.

A 2022 survey by the International Pharmaceutical Excipients Council revealed that 72% of North American consumers prefer purchasing medications in specialty capsule formats like gastro-resistant or controlled-release.

The U.S. Council for Responsible Nutrition reported that the North American nutraceuticals market reached USD 60 Billion in 2021, a 7.5% increase from 2020 levels.

Health Canada data shows that the value of natural health product licenses, which often utilize empty capsules, grew by 9% in the country from 2020 to 2022.

Asia Pacific

Asia Pacific is anticipated to witness the fastest growth in the empty capsules market during the forecast period owing to the expanding pharmaceutical and nutraceuticals industry.

According to the India Brand Equity Foundation, the Indian pharmaceutical industry grew by 18.8% in 2021 to reach $42 billion, driving greater demand for empty capsules.

A 2022 report by the Japan Health and Nutrition Food Association found that the Japanese nutraceuticals market reached $30 billion, up 12% from 2020 levels.

The China Vegetarian Association reported a 20% increase in the sales of plant-based supplements packaged in vegetarian capsules from 2020 to 2022.

A 2021 survey by the International Pharmaceutical Excipients Council found that 68% of consumers in the Asia Pacific region actively seek out clean-label and non-animal-derived capsule products.

The OECD reported that China's per capita healthcare expenditure grew by 9.2% annually from 2020 to 2022, improving access to medicines packaged in empty capsules.

The Indian government's 2022 budget allocated $10 billion towards expanding the country's universal healthcare coverage, which is expected to drive greater pharmaceutical consumption.

Global Empty Capsules Market: Segmentation Analysis

The Global Empty Capsules Market is segmented based on End-User Industry, Product, Therapeutic Application, And Geography.

Empty Capsules Market, By End-User Industry

Pharmaceutical Industry
Nutraceutical Industry
Cosmetics Business
Clinical Research Organization

Based on the End-User Industry, the Global Empty Capsules Market is bifurcated into the Pharmaceutical Industry, Nutraceutical Industry, Cosmetics Business, and Clinical Research Organization. The Pharmaceutical segment is experiencing growth in the Global Empty Capsules Market owing to the increasing production and usage of a wide range of drugs by healthcare practitioners. Empty capsules are extensively utilized in the pharmaceutical industry for the treatment of infectious and chronic diseases, as they help extend the shelf life of active ingredients in medications.

Empty Capsules Market, By Product

Gelatin
Non-Gelatin

Based on the Product, the Global Empty Capsules Market is bifurcated into Gelatin and Non-Gelatin. The Gelatin segment dominates in the Global Empty Capsules Market. The gelatin-based empty capsules are made from various sources, including pig meat gelatin, bovine-derived gelatin, and bone meal gelatin. These capsules are composed of pure protein, are tasteless, and are both gluten-free and GMO-free. Furthermore, they are customized in terms of color, shape, and size to meet specific needs and accommodate diverse demographics.

Empty Capsules Market, By Therapeutic Application

Antibiotic and Antibacterial Drugs
Vitamins and Dietary Supplements
Antacid and Antiflatulent Preparations
Anti-inflammatory Drugs
Antianemic Preparations

Based on the Therapeutic Application, the Global Empty Capsules Market is bifurcated into Antibiotic and Antibacterial Drugs, Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Anit-inflammatory Drugs, and Antianemic Preparations. The Antibiotic and Antibacterial Drugs segment dominates in the Global Empty Capsules Market owing to high demand for commonly used drugs such as penicillin, tetracycline, sulfonamide, and nitrofurantoin. Rising cases of bacterial infections, including tuberculosis, and bladder, and gastrointestinal infections, continue to drive demand for these medications. Additionally, ongoing research and development in antibiotic and antibacterial drugs further support market growth.

Key Players

The "Global Empty Capsules Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Capsugel (now Lonza), ACG Worldwide, Qualicaps, Suheung Co., Ltd., CapsCanada Corporation, Sunil Healthcare Limited, Shanxi Guangsheng Medicinal Capsules Co., Ltd., Bright Pharma Caps, Inc., Snail Pharma Industry Co., Ltd., Natural Capsules Limited.

This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Empty Capsules Market Key Developments

In March 2023, VANTAGE NUTRITION, an ACG company, announced the acquisition of ComboCap, Inc. in the United States and BioCap in South Africa, with plans to grow their technology and footprint in North America and around the world.
In January 2022, Xi'an Le-Nutra Ingredients Inc. exported 8.0 million HPMC capsules to Latvia, Europe. These capsules did not contain titanium dioxide (TiO2), reflecting the company's efforts to accommodate regional demand for the product.
In July 2020, QUALICAPS Group, which was previously part of Mitsubishi Chemical Holdings Corporation (MCHC), was transferred to Mitsubishi Chemical Corporation (MCC). This transition enables QUALICAPS to make use of its network and increase its capsule business.

1 INTRODUCTION OF GLOBAL EMPTY CAPSULES MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL EMPTY CAPSULES MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL EMPTY CAPSULES MARKET, BY END-USER INDUSTRY

5.1 Overview
5.2 Pharmaceutical Industry
5.3 Nutraceutical Industry
5.4 Cosmetics Business
5.5 Clinical Research Organization

6 GLOBAL EMPTY CAPSULES MARKET, BY PRODUCT

6.1 Overview
6.2 Gelatin
6.3 Non-Gelatin

7 GLOBAL EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION

7.1 Overview
7.2 Antibiotic and Antibacterial Drugs
7.3 Vitamins and Dietary Supplements
7.4 Antacid and Antiflatulent Preparations
7.5 Anti-inflammatory Drugs
7.6 Antianemic Preparations

8 GLOBAL EMPTY CAPSULES MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL EMPTY CAPSULES MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market ranking
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES

10.1 Capsugel (now Lonza)
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 ACG Worldwide
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Qualicaps
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Suheung Co. Ltd.
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 CapsCanada Corporation
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Sunil Healthcare Limited
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Shanxi Guangsheng Medicinal Capsules Co. Ltd
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Bright Pharma Caps, Inc.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Snail Pharma Industry Co. Ltd.
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Natural Capsules Limited
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments